Shilpa Gupta

Shilpa Gupta is Director of Genitourinary Medical Oncology at Cleveland Clinic Taussig Cancer Institute. She is a genitourinary oncologist known for leading bladder and kidney cancer trials, as an investigator on enfortumab vedotin, immunotherapy and adjuvant renal cell carcinoma studies, and for national guideline work as co-chair of national bladder cancer committees. Her selected paper reports enfortumab vedotin plus pembrolizumab in previously untreated advanced urothelial cancer. She directs GU medical oncology at Cleveland Clinic and continues immunotherapy trials in bladder and kidney cancer.